microdose glp 1 for menopause Jill Microdosing GLP-1 in Perimenopause &

10.18388/pb.2021_605 46

More severe spectrum: Gastroparesis (HR ~1.6 vs other agents) [16] Functional obstruction (gastric or small bowel dilation without transition point) ED management: Behavioural strategies & dietary strategies: Smaller meals, Eating slowly, Avoiding high-fat foods, alcohol & carbonation, High fiber diet

Joint and Tendon Support In addition, many patients turn to BPC-157 for tendon, ligament, and joint concerns

Gastrointestinal and tendon/ligament research: BPC-157 has the most consistent preclinical signal here, including reported reductions in gastric ulcer surface area and accelerated tendon healing in rodent models

Elevated NNMT is a consistent feature in obesity research across species, making it a key area of preclinical investigation